NASDAQ:INGN - Inogen Stock Price, Price Target & More

$138.49 -3.77 (-2.65 %)

(As of 04/25/2018 08:30 AM ET)

Previous Close$142.26

Today's Range$137.01 - $143.67

52-Week Range$80.04 - $144.31

Volume121,600 shs

Average Volume140,353 shs

Market Capitalization$3.02 billion

P/E Ratio110.28

Dividend YieldN/A

Beta1.03

About Inogen (NASDAQ:INGN)

Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. The company's oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; and Inogen At Home stationary oxygen concentrators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was founded in 2001 and is headquartered in Goleta, California.

Receive INGN News and Ratings via Email

Sign-up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical appliances & supplies

Sub-IndustryN/A

SectorMedical

SymbolNASDAQ:INGN

CUSIPN/A

Webwww.inogen.com

Phone805-562-0500

Debt

Debt-to-Equity RatioN/A

Current Ratio6.74%

Quick Ratio6.19%

Price-To-Earnings

Trailing P/E Ratio110.28

Forward P/E Ratio86.56

P/E Growth3.96

Sales & Book Value

Annual Sales$249.44 million

Price / Sales11.78

Cash Flow$1.9068 per share

Price / Cash72.63

Book Value$10.88 per share

Price / Book12.73

Profitability

EPS (Most Recent Fiscal Year)$1.31

Net Income$21 million

Net Margins8.42%

Return on Equity13.47%

Return on Assets11.17%

Miscellaneous

Employees770

Outstanding Shares21,210,000

How to Become a New Pot Stock Millionaire

Inogen (NASDAQ:INGN) Frequently Asked Questions

What is Inogen's stock symbol?

Inogen trades on the NASDAQ under the ticker symbol "INGN."

How were Inogen's earnings last quarter?

Inogen (NASDAQ:INGN) announced its quarterly earnings data on Tuesday, February, 27th. The medical technology company reported $0.31 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.21 by $0.10. The medical technology company had revenue of $63.79 million for the quarter, compared to analyst estimates of $62.01 million. Inogen had a net margin of 8.42% and a return on equity of 13.47%. View Inogen's Earnings History.

When is Inogen's next earnings date?

Inogen is scheduled to release their next quarterly earnings announcement on Monday, April, 30th 2018. View Earnings Estimates for Inogen.

What price target have analysts set for INGN?

5 brokerages have issued 1 year price targets for Inogen's stock. Their forecasts range from $75.00 to $150.00. On average, they expect Inogen's stock price to reach $118.40 in the next twelve months. View Analyst Ratings for Inogen.

Who are some of Inogen's key competitors?

Some companies that are related to Inogen include William Demant (WILYY), STERIS (STE), Mine Safety Appliances (MSA), Halyard Health (HYH), Wright Medical Group (WMGI), Consort Medical (CSRMY), Invacare (IVC), RTI Surgical (RTIX), Sientra (SIEN), Lakeland Industries (LAKE), ConforMIS (CFMS), Histogenics (HSGX), BioCardia (BCDA), ReWalk Robotics (RWLK) and NanoVibronix (NAOV).

Who are Inogen's key executives?

Inogen's management team includes the folowing people:

Mr. Scott Wilkinson, CEO, Pres & Director (Age 53)
Mr. Brenton Taylor, Exec. VP of Engineering (Age 37)
Ms. Alison Perry Bauerlein, Exec. VP of Fin., CFO, Sec. & Treasurer (Age 37)
Mr. Matthew S. Scribner, Exec. VP of Operations (Age 51)
Mr. Byron Myers, Exec. VP of Sales & Marketing (Age 39)

Has Inogen been receiving favorable news coverage?

News stories about INGN stock have trended somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Inogen earned a daily sentiment score of 0.07 on Accern's scale. They also assigned news stories about the medical technology company an impact score of 44.89 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.

How do I buy shares of Inogen?

Shares of INGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Inogen's stock price today?

One share of INGN stock can currently be purchased for approximately $138.49.

How big of a company is Inogen?

Inogen has a market capitalization of $3.02 billion and generates $249.44 million in revenue each year. The medical technology company earns $21 million in net income (profit) each year or $1.31 on an earnings per share basis. Inogen employs 770 workers across the globe.

How can I contact Inogen?

Inogen's mailing address is 326 BOLLAY DRIVE, GOLETA CA, 93117. The medical technology company can be reached via phone at 805-562-0500 or via email at [email protected]

MarketBeat Community Rating for Inogen (INGN)

Community Ranking:		3.3 out of 5 ( )
Outperform Votes:		228 (Vote Outperform)
Underperform Votes:		114 (Vote Underperform)
Total Votes:		342

MarketBeat's community ratings are surveys of what our community members think about Inogen and other stocks. Vote "Outperform" if you believe INGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INGN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Inogen (NASDAQ:INGN) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

5 Wall Street analysts have issued ratings and price targets for Inogen in the last 12 months. Their average twelve-month price target is $118.40, suggesting that the stock has a possible downside of 14.51%. The high price target for INGN is $150.00 and the low price target for INGN is $75.00. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Hold
Consensus Rating Score:	2.80	2.83	2.67	2.40
Ratings Breakdown:	0 Sell Rating(s) 1 Hold Rating(s) 4 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 2 Hold Rating(s) 3 Buy Rating(s) 1 Strong Buy Rating(s)	0 Sell Rating(s) 3 Hold Rating(s) 2 Buy Rating(s) 1 Strong Buy Rating(s)	0 Sell Rating(s) 3 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$118.40	$102.6667	$98.50	$90.80
Price Target Upside:	14.51% downside	21.20% downside	16.61% downside	13.10% downside

Inogen (NASDAQ:INGN) Consensus Price Target History

Price Target History for Inogen (NASDAQ:INGN)

Inogen (NASDAQ:INGN) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/14/2018	Piper Jaffray	Set Price Target	Buy	$145.00	Low
3/27/2018	Needham & Company LLC	Reiterated Rating	Buy	$150.00	High
11/8/2017	Leerink Swann	Reiterated Rating	Outperform	$115.00 -> $120.00	N/A
6/26/2017	JPMorgan Chase	Boost Price Target	Overweight	$102.00	Low
5/10/2017	Stifel Nicolaus	Boost Price Target	Hold -> Hold	$65.00 -> $75.00	High
4/18/2017	Sidoti	Initiated Coverage	Neutral -> Neutral	$79.00	Medium

(Data available from 4/25/2016 forward)

Inogen (NASDAQ:INGN) Earnings History and Estimates Chart

Earnings by Quarter for Inogen (NASDAQ:INGN)

Inogen (NASDAQ:INGN) Earnings Estimates

2018 EPS Consensus Estimate: $1.55
2019 EPS Consensus Estimate: $1.71

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	2	$0.27	$0.29	$0.28
Q2 2018	2	$0.43	$0.52	$0.48
Q3 2018	2	$0.41	$0.49	$0.45
Q4 2018	2	$0.27	$0.41	$0.34
Q1 2019	2	$0.32	$0.33	$0.33
Q2 2019	2	$0.49	$0.53	$0.51
Q3 2019	2	$0.47	$0.53	$0.50
Q4 2019	2	$0.31	$0.44	$0.38

Inogen (NASDAQ INGN) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
4/30/2018		$0.29					N/A
2/27/2018	Q4 2017	$0.21	$0.31	$62.01 million	$63.79 million	View	N/A
11/7/2017	Q3 2017	$0.29	$0.33	$63.55 million	$69.00 million	View	N/A
8/3/2017	Q2 2017	$0.28	$0.38	$59.99 million	$64.10 million	View	Listen
5/9/2017	Q1 2017	$0.12	$0.27	$49.06 million	$52.50 million	View	Listen
2/28/2017	Q416	$0.10	$0.25	$46.19 million	$50.85 million	View	Listen
11/3/2016	Q316	$0.13	$0.16	$47.89 million	$54.42 million	View	N/A
8/4/2016	Q216	$0.20	$0.25	$52.44 million	$54.57 million	View	N/A
5/9/2016	Q116	$0.12	$0.11	$41.75 million	$43.00 million	View	N/A
3/14/2016	Q415	$0.07	$0.19	$29.10 million	$40.40 million	View	N/A
11/10/2015	Q315	$0.13	$0.13	$36.99 million	$40.80 million	View	Listen
8/11/2015	Q215	$0.15	$0.17	$36.88 million	$44.00 million	View	Listen
5/12/2015	Q1	$0.07	$0.08	$29.98 million	$33.70 million	View	Listen
4/27/2015	Q115	$0.03	$0.06	$19.80 million	$29.10 million	View	N/A
11/11/2014	Q3 2014	$0.06	$0.11	$28.00 million	$29.40 million	View	N/A
8/12/2014	Q214	$0.07	$0.11	$23.93 million	$30.40 million	View	N/A
5/13/2014	Q114	$0.04	$0.05	$20.70 million	$23.60 million	View	N/A
3/27/2014	Q4 13	$0.02	$0.89	$18.71 million	$19.76 million	View	N/A

(Earnings results data provided by Zacks Investment Research)

Inogen (NASDAQ:INGN) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Inogen (NASDAQ INGN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.29%
Institutional Ownership Percentage: 98.87%

Insider Trading History for Inogen (NASDAQ:INGN)

Institutional Ownership by Quarter for Inogen (NASDAQ:INGN)

Inogen (NASDAQ INGN) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/17/2018	Ray Benjamin M Anderson	Director	Sell	1,000	$139.82	$139,820.00	1,000
4/16/2018	Matt Scribner	EVP	Sell	2,500	$139.79	$349,475.00	8,374
3/15/2018	Matt Scribner	EVP	Sell	2,500	$127.95	$319,875.00
3/8/2018	Alison Bauerlein	EVP	Sell	15,911	$124.48	$1,980,601.28	20,072
3/1/2018	Heath Lukatch	Director	Sell	2,500	$119.15	$297,875.00	2,500
2/26/2018	Heather D Rider	Director	Sell	5,222	$131.13	$684,760.86	3,222
2/21/2018	Brenton Taylor	EVP	Sell	5,000	$130.76	$653,800.00	38,982
2/20/2018	Alison Bauerlein	CFO	Sell	3,192	$125.41	$400,308.72	8,808
2/16/2018	Alison Bauerlein	CFO	Sell	8,808	$125.03	$1,101,264.24	8,808
2/16/2018	Brenton Taylor	EVP	Sell	5,000	$125.06	$625,300.00	38,982
2/14/2018	Alison Bauerlein	CFO	Sell	9,737	$120.05	$1,168,926.85	9,737
2/14/2018	Brenton Taylor	EVP	Sell	15,000	$117.47	$1,762,050.00	38,982
2/12/2018	Alison Bauerlein	EVP	Sell	27,630	$116.46	$3,217,789.80	11,718
2/9/2018	Alison Bauerlein	CFO	Sell	11,718	$115.87	$1,357,764.66	11,718
1/16/2018	Matt Scribner	EVP	Sell	2,500	$116.17	$290,425.00	7,297
1/16/2018	Raymond Huggenberger	Director	Sell	13,000	$116.19	$1,510,470.00	10,208
1/16/2018	Scott Wilkinson	Insider	Sell	30,651	$115.75	$3,547,853.25	38,107
1/2/2018	Ray Benjamin M Anderson	Director	Sell	1,000	$119.06	$119,060.00	1,000
12/15/2017	Raymond Huggenberger	Director	Sell	14,000	$119.92	$1,678,880.00	7,808
12/14/2017	Matt Scribner	EVP	Sell	2,500	$120.34	$300,850.00	7,297
12/11/2017	Byron Myers	EVP	Sell	10,000	$116.81	$1,168,100.00	48,600
12/1/2017	Heath Lukatch	Director	Sell	2,500	$126.40	$316,000.00
11/17/2017	Byron Myers	EVP	Sell	35,000	$116.77	$4,086,950.00	48,600
11/13/2017	Matt Scribner	EVP	Sell	2,500	$112.35	$280,875.00
10/16/2017	Raymond Huggenberger	Director	Sell	14,000	$94.07	$1,316,980.00	7,808
10/12/2017	Matt Scribner	EVP	Sell	2,500	$93.88	$234,700.00
10/10/2017	Alison Bauerlein	EVP	Sell	15,000	$94.93	$1,423,950.00
9/15/2017	Raymond Huggenberger	Director	Sell	14,000	$102.30	$1,432,200.00	7,808
9/11/2017	Matt Scribner	EVP	Sell	2,500	$103.23	$258,075.00	6,964
9/6/2017	Heath Lukatch	Director	Sell	2,500	$97.44	$243,600.00	2,500
8/18/2017	Matt Scribner	EVP	Sell	2,500	$92.45	$231,125.00	6,964
8/15/2017	Raymond Huggenberger	Director	Sell	14,000	$91.67	$1,283,380.00	7,808
8/10/2017	Alison Bauerlein	EVP	Sell	6,667	$92.64	$617,630.88	15,000
7/18/2017	Matt Scribner	EVP	Sell	2,500	$94.21	$235,525.00	4,833
7/14/2017	Raymond Huggenberger	Director	Sell	14,000	$92.96	$1,301,440.00	7,808
6/16/2017	Matt Scribner	EVP	Sell	2,500	$91.54	$228,850.00	4,833
6/15/2017	Raymond Huggenberger	Director	Sell	15,300	$90.88	$1,390,464.00	7,808
6/2/2017	Byron Myers	EVP	Sell	10,000	$90.00	$900,000.00	45,185
6/1/2017	Scott Wilkinson	Insider	Sell	23,437	$88.06	$2,063,862.22	54,088
5/30/2017	Heath Lukatch	Director	Sell	9,000	$88.52	$796,680.00	7,246
5/18/2017	Ray Benjamin M Anderson	Director	Sell	4,445	$81.05	$360,267.25	4,445
5/10/2017	Alison Bauerlein	EVP	Sell	6,666	$83.24	$554,877.84	25,758
4/24/2017	Byron Myers	EVP	Sell	10,000	$80.00	$800,000.00	45,185
4/17/2017	Matt Scribner	EVP	Sell	2,500	$75.28	$188,200.00	4,064
3/15/2017	Matt Scribner	EVP	Sell	2,500	$73.85	$184,625.00	4,833
2/28/2017	Brenton Taylor	EVP	Sell	3,750	$70.07	$262,762.50	31,851
1/17/2017	Matt Scribner	EVP	Sell	2,500	$63.91	$159,775.00	4,833
1/17/2017	Raymond Huggenberger	CEO	Sell	5,680	$63.96	$363,292.80	12,488
1/10/2017	Brenton Taylor	EVP	Sell	5,105	$65.31	$333,407.55	31,851
1/3/2017	Brenton Taylor	EVP	Sell	31,823	$65.69	$2,090,452.87	63,674
12/15/2016	Raymond Huggenberger	CEO	Sell	8,000	$65.59	$524,720.00	14,808
12/14/2016	Matt Scribner	EVP	Sell	2,500	$65.13	$162,825.00	4,833
12/1/2016	Scott Wilkinson	Insider	Sell	26,706	$61.64	$1,646,157.84	66,050
11/14/2016	Matt Scribner	EVP	Sell	2,500	$63.80	$159,500.00	4,833
10/17/2016	Raymond Huggenberger	CEO	Sell	7,089	$56.24	$398,685.36	8,342
10/12/2016	Matt Scribner	EVP	Sell	4,551	$59.45	$270,556.95	6,884
9/19/2016	Matt Scribner	EVP	Sell	4,551	$60.18	$273,879.18	6,884
9/16/2016	Byron Myers	VP	Sell	6,200	$60.04	$372,248.00	41,385
9/9/2016	Byron Myers	VP	Sell	3,800	$60.07	$228,266.00	35,585
8/18/2016	Matt Scribner	EVP	Sell	2,320	$56.39	$130,824.80	4,653
8/15/2016	Raymond Huggenberger	CEO	Sell	20,747	$57.48	$1,192,537.56	27,555
8/9/2016	Byron Myers	VP	Sell	13,000	$55.00	$715,000.00	35,185
7/18/2016	Matt Scribner	EVP	Sell	4,102	$50.46	$206,986.92	6,435
7/18/2016	Raymond Huggenberger	CEO	Sell	20,747	$50.41	$1,045,856.27	27,555
6/16/2016	Matt Scribner	EVP	Sell	4,102	$47.66	$195,501.32	2,738
6/16/2016	Raymond Huggenberger	CEO	Sell	20,747	$47.86	$992,951.42	27,555
5/16/2016	Matt Scribner	EVP	Sell	4,102	$43.82	$179,749.64	6,435
5/16/2016	Raymond Huggenberger	CEO	Sell	20,746	$44.18	$916,558.28	27,554
4/15/2016	Matt Scribner	EVP	Sell	4,102	$48.62	$199,439.24	6,435
4/15/2016	Raymond Huggenberger	CEO	Sell	29,635	$48.59	$1,439,964.65	25,210
4/13/2016	Brenton Taylor	EVP	Sell	6,500	$48.00	$312,000.00	31,851
4/6/2016	Alison Bauerlein	CFO	Sell	9,278	$46.18	$428,458.04	38,332
3/31/2016	Alison Bauerlein	CFO	Sell	4,360	$44.33	$193,278.80	48,332
2/16/2016	Matt Scribner	EVP	Sell	4,102	$30.26	$124,126.52	2,333
1/14/2016	Matt Scribner	EVP	Sell	4,102	$34.73	$142,462.46	2,333
12/14/2015	Matt Scribner	EVP	Sell	4,102	$40.40	$165,720.80	2,333
11/12/2015	Matt Scribner	EVP	Sell	4,102	$44.52	$182,621.04	2,333
10/26/2015	Brenton Taylor	EVP	Sell	5,000	$41.38	$206,900.00	43,351
10/21/2015	Raymond Huggenberger	CEO	Sell	57,418	$43.06	$2,472,419.08	6,808
10/12/2015	Matt Scribner	EVP	Sell	4,102	$44.06	$180,734.12	2,333
10/1/2015	Alison Bauerlein	CFO	Sell	10,185	$47.94	$488,268.90	43,890
9/25/2015	Brenton Taylor	EVP	Sell	3,333	$53.48	$178,248.84	43,351
9/16/2015	Byron Myers	VP	Sell	1,700	$55.00	$93,500.00	36,332
9/15/2015	Raymond Huggenberger	CEO	Sell	57,416	$53.58	$3,076,349.28	6,808
9/14/2015	Byron Myers	VP	Sell	7,950	$55.23	$439,078.50	36,332
9/10/2015	Matt Scribner	EVP	Sell	4,102	$53.30	$218,636.60	4,666
9/1/2015	Alison Bauerlein	CFO	Sell	6,500	$48.21	$313,365.00	49,075
8/26/2015	Scott Wilkinson	EVP	Sell	6,666	$45.42	$302,769.72
8/25/2015	Brenton Taylor	EVP	Sell	3,333	$46.84	$156,117.72	46,684
8/25/2015	Ray Benjamin M. Anderson	Director	Sell	5,658	$46.36	$262,304.88	4,896
5/28/2015	Timothy Petersen	Director	Sell	337,081	$37.44	$12,620,312.64
5/26/2015	Timothy Petersen	Director	Sell	54,258	$37.05	$2,010,258.90
5/22/2015	Timothy Petersen	Director	Sell	86,889	$37.09	$3,222,713.01
5/21/2015	Timothy Petersen	Director	Sell	134,300	$37.81	$5,077,883.00
5/19/2015	Timothy Petersen	Director	Sell	115,700	$37.25	$4,309,825.00
5/18/2015	Timothy Petersen	Director	Sell	58,987	$37.35	$2,203,164.45
3/5/2015	Matt Scribner	EVP	Sell	4,102	$33.69	$138,196.38
2/25/2015	Brenton Taylor	EVP	Sell	15,687	$33.87	$531,318.69
2/23/2015	Alison Bauerlein	CFO	Sell	15,687	$33.10	$519,239.70
2/19/2015	Raymond Huggenberger	CEO	Sell	25,722	$33.95	$873,261.90
2/13/2015	Scott Wilkinson	EVP	Sell	18,333	$32.87	$602,605.71
2/5/2015	Matt Scribner	EVP	Sell	4,102	$30.66	$125,767.32
2/3/2015	Timothy Petersen	Director	Sell	17,000	$30.25	$514,250.00
2/2/2015	Timothy Petersen	Director	Sell	99,000	$30.88	$3,057,120.00
1/29/2015	Timothy Petersen	Director	Sell	601,000	$31.95	$19,201,950.00
1/26/2015	Brenton Taylor	EVP	Sell	15,687	$31.53	$494,611.11
1/23/2015	Alison Bauerlein	CFO	Sell	15,687	$31.53	$494,611.11
1/20/2015	Raymond Huggenberger	CEO	Sell	25,722	$31.63	$813,586.86
1/5/2015	Matt Scribner	EVP	Sell	4,102	$31.14	$127,736.28
1/5/2015	Versant Ventures Ii Llc	Major Shareholder	Sell	7,946	$30.98	$246,167.08
12/30/2014	Scott Wilkinson	EVP	Sell	962	$30.50	$29,341.00
12/29/2014	Scott Wilkinson	EVP	Sell	15,735	$30.52	$480,232.20
12/24/2014	Byron Myers	VP	Sell	7,514	$30.07	$225,945.98
12/23/2014	Alison Bauerlein	CFO	Sell	15,687	$29.85	$468,256.95
12/23/2014	Byron Myers	VP	Sell	3,018	$30.04	$90,660.72
12/23/2014	Versant Ventures Ii Llc	Major Shareholder	Sell	9,785	$29.74	$291,005.90
12/22/2014	Byron Myers	VP	Sell	11,801	$30.06	$354,738.06
12/22/2014	Scott Wilkinson	EVP	Sell	1,033	$30.31	$31,310.23
12/19/2014	Raymond Huggenberger	CEO	Sell	25,722	$28.98	$745,423.56
12/11/2014	Scott Wilkinson	EVP	Sell	14,700	$25.25	$371,175.00
12/3/2014	Matt Scribner	EVP	Sell	4,102	$24.09	$98,817.18
11/25/2014	Brenton Taylor	EVP	Sell	15,687	$24.71	$387,625.77
11/21/2014	Alison Bauerlein	CFO	Sell	15,687	$24.49	$384,174.63
11/19/2014	Raymond Huggenberger	CEO	Sell	25,722	$24.25	$623,758.50
11/19/2014	Versant Ventures Ii Llc	Major Shareholder	Sell	28,225	$24.77	$699,133.25
11/18/2014	Scott Wilkinson	EVP	Sell	2,233	$25.21	$56,293.93
11/18/2014	Versant Ventures Ii Llc	Major Shareholder	Sell	11,848	$24.83	$294,185.84
11/17/2014	Versant Ventures Ii Llc	Major Shareholder	Sell	5,343	$24.89	$132,987.27
11/14/2014	Heather D Rider	Director	Buy	3,000	$25.00	$75,000.00
11/14/2014	Scott Wilkinson	EVP	Sell	1,100	$25.15	$27,665.00
11/14/2014	Versant Ventures Ii Llc	Major Shareholder	Sell	9,433	$25.13	$237,051.29
11/10/2014	Versant Ventures Ii Llc	Major Shareholder	Sell	2,992	$24.42	$73,064.64
11/7/2014	Versant Ventures Ii Llc	Major Shareholder	Sell	7,388	$24.30	$179,528.40
11/4/2014	A/S Novo	Major Shareholder	Sell	2,000,000	$21.50	$43,000,000.00
11/4/2014	Raymond Huggenberger	CEO	Sell	165,891	$20.21	$3,352,657.11
11/4/2014	Timothy Petersen	Director	Sell	250,000	$21.50	$5,375,000.00
11/3/2014	Matt Scribner	EVP	Sell	4,102	$24.08	$98,776.16
10/29/2014	Scott Wilkinson	EVP	Sell	18,333	$22.41	$410,842.53
10/27/2014	Brenton Taylor	EVP	Sell	15,687	$21.67	$339,937.29
10/24/2014	Versant Ventures Ii Llc	Major Shareholder	Sell	4,647	$20.76	$96,471.72
10/23/2014	Alison Bauerlein	CFO	Sell	15,687	$20.50	$321,583.50
10/9/2014	Versant Ventures Ii Llc	Major Shareholder	Sell	1,900	$20.83	$39,577.00
10/8/2014	Versant Ventures Ii Llc	Major Shareholder	Sell	6,907	$21.03	$145,254.21
10/7/2014	Timothy Petersen	Director	Sell	31,600	$21.55	$680,980.00
10/6/2014	Timothy Petersen	Director	Sell	17,475	$21.56	$376,761.00
10/3/2014	Timothy Petersen	Director	Sell	31,658	$21.52	$681,280.16
10/3/2014	Ventures Lp Arboretum II	Major Shareholder	Sell	98,400	$20.97	$2,063,448.00
10/2/2014	Timothy Petersen	Director	Sell	24,597	$20.91	$514,323.27
10/1/2014	Matt Scribner	EVP	Sell	8,204	$20.25	$166,131.00
10/1/2014	Timothy Petersen	Director	Sell	42,145	$20.61	$868,608.45
9/30/2014	Timothy Petersen	Director	Sell	84,500	$20.23	$1,709,435.00
9/24/2014	Ventures Lp Arboretum II	Major Shareholder	Sell	83,500	$20.34	$1,698,390.00
9/23/2014	Alison Bauerlein	CFO	Sell	15,687	$20.01	$313,896.87
9/22/2014	Raymond Huggenberger	CEO	Sell	25,722	$20.25	$520,870.50
9/22/2014	Timothy Petersen	Director	Sell	46,865	$21.05	$986,508.25
9/17/2014	Timothy Petersen	Director	Sell	39,135	$21.72	$850,012.20
9/17/2014	Ventures Lp Arboretum II	Major Shareholder	Sell	55,135	$21.61	$1,191,467.35
9/16/2014	Timothy Petersen	Director	Sell	6,500	$21.16	$137,540.00
9/15/2014	Byron Myers	VP	Sell	22,333	$21.33	$476,362.89
9/15/2014	Scott Wilkinson	EVP	Sell	18,333	$21.42	$392,692.86
9/15/2014	Timothy Petersen	Director	Sell	9,500	$21.45	$203,775.00
9/9/2014	Versant Ventures Ii Llc	Major Shareholder	Sell	7,388	$23.25	$171,771.00
3/7/2014	Charles E Larsen	Director	Sell	26,201	$14.88	$389,870.88
2/20/2014	A/S Novo	Insider	Sell	617,000	$14.88	$9,180,960.00
2/20/2014	Loren L Mcfarland	Director	Buy	3,125	$16.00	$50,000.00

(Data available from 1/1/2013 forward)

Inogen (NASDAQ INGN) News Headlines

Source:

Date	Headline
	Inogen (INGN) Set to Announce Quarterly Earnings on Monday www.americanbankingnews.com - April 23 at 8:16 PM
	Ray Benjamin M. Anderson Sells 1,000 Shares of Inogen (INGN) Stock www.americanbankingnews.com - April 19 at 7:36 PM
	Inogen to Announce First Quarter 2018 Financial Results on Monday, April 30, 2018 finance.yahoo.com - April 19 at 4:55 PM
	Head-To-Head Survey: Align Technology (ALGN) and Inogen (INGN) www.americanbankingnews.com - April 18 at 11:08 PM
	Form 4 Inogen Inc For: Apr 16 Filed by: Scribner Matt www.streetinsider.com - April 18 at 5:01 PM
	Matt Scribner Sells 2,500 Shares of Inogen (INGN) Stock www.americanbankingnews.com - April 17 at 10:33 PM
	Inogen (INGN) Expected to Post Quarterly Sales of $62.60 Million www.americanbankingnews.com - April 17 at 2:32 AM
	Invacare (IVC) & Inogen (INGN) Head-To-Head Contrast www.americanbankingnews.com - April 15 at 7:19 PM
	$0.27 EPS Expected for Inogen (INGN) This Quarter www.americanbankingnews.com - April 15 at 7:18 PM
	Piper Jaffray Reiterates $145.00 Price Target for Inogen (INGN) www.americanbankingnews.com - April 15 at 8:35 AM
	Inogen (INGN) Stock Rating Lowered by BidaskClub www.americanbankingnews.com - April 14 at 10:53 PM
	Health Care Sector Update for 04/13/2018: CDNA,PLSE,IPCT,INGN www.nasdaq.com - April 13 at 4:47 PM
	Oxygen device maker Inogen discloses customer data breach finance.yahoo.com - April 13 at 4:47 PM
	Inogen discloses data breach www.nasdaq.com - April 13 at 9:23 AM
	Medical device maker Inogen discloses data breach www.reuters.com - April 13 at 9:23 AM
	BRIEF-Inogen Discloses Data Breach www.reuters.com - April 13 at 9:23 AM
	Inogen (INGN) Lowered to "Hold" at Zacks Investment Research www.americanbankingnews.com - April 12 at 7:25 PM
	Inogen (INGN) Upgraded to "Strong-Buy" at BidaskClub www.americanbankingnews.com - April 12 at 6:15 PM
	Inogen (INGN) Receives Consensus Recommendation of "Buy" from Analysts www.americanbankingnews.com - April 12 at 9:07 AM
	ValuEngine Upgrades Inogen (INGN) to Buy www.americanbankingnews.com - April 6 at 11:38 AM
	Inogen (INGN) Raised to Strong-Buy at BidaskClub www.americanbankingnews.com - April 6 at 11:07 AM
	Validea Motley Fool Strategy Daily Upgrade Report - 4/3/2018 www.nasdaq.com - April 3 at 9:22 AM
	Needham & Company LLC Raises Inogen (INGN) Price Target to $125.00 www.americanbankingnews.com - April 1 at 11:24 AM
	Zacks: Analysts Anticipate Inogen (INGN) Will Post Quarterly Sales of $62.60 Million www.americanbankingnews.com - March 31 at 1:56 AM
	Brokerages Expect Inogen (INGN) to Announce $0.27 EPS www.americanbankingnews.com - March 29 at 11:26 PM
	Why Is Inogen (INGN) Down 7% Since its Last Earnings Report? finance.yahoo.com - March 29 at 4:44 PM
	Inogen (INGN) Downgraded to Hold at Zacks Investment Research www.americanbankingnews.com - March 29 at 12:19 PM
	Inogen (INGN) Earns Buy Rating from Needham & Company LLC www.americanbankingnews.com - March 27 at 1:16 PM
	Inogen Inc (INGN) EVP Sells $319,875.00 in Stock www.americanbankingnews.com - March 19 at 10:12 PM
	Inogen Inc (INGN) Given Consensus Recommendation of "Buy" by Brokerages www.americanbankingnews.com - March 18 at 9:11 AM
	Inogen Announces Participation in 17th Annual Needham Healthcare Conference finance.yahoo.com - March 14 at 6:08 PM
	Zacks: Analysts Expect Inogen Inc (INGN) Will Post Quarterly Sales of $62.60 Million www.americanbankingnews.com - March 14 at 2:54 AM
	Contrasting Inogen (INGN) & Cardiovascular Systems (CSII) www.americanbankingnews.com - March 12 at 1:44 PM
	BidaskClub Upgrades Inogen (INGN) to Buy www.americanbankingnews.com - March 10 at 6:00 PM
	Alison Bauerlein Sells 15,911 Shares of Inogen Inc (INGN) Stock www.americanbankingnews.com - March 9 at 9:16 PM
	WINTON GROUP Ltd Acquires Shares of 49,331 Inogen Inc (INGN) www.americanbankingnews.com - March 6 at 3:35 PM
	Schwab Charles Investment Management Inc. Acquires 2,327 Shares of Inogen Inc (INGN) www.americanbankingnews.com - March 6 at 5:56 AM
	Swiss National Bank Has $3.63 Million Position in Inogen Inc (INGN) www.americanbankingnews.com - March 5 at 4:03 PM
	Inogen Inc (INGN) Shares Sold by Wells Fargo & Company MN www.americanbankingnews.com - March 5 at 3:11 PM
	Inogen (INGN) Downgraded to "Hold" at Zacks Investment Research www.americanbankingnews.com - March 5 at 1:36 PM
	19,102 Shares in Inogen Inc (INGN) Purchased by Bogle Investment Management L P DE www.americanbankingnews.com - March 5 at 5:10 AM
	Q1 2018 EPS Estimates for Inogen Inc (INGN) Lowered by Analyst www.americanbankingnews.com - March 5 at 2:08 AM
	OppenheimerFunds Inc. Has $22.31 Million Position in Inogen Inc (INGN) www.americanbankingnews.com - March 4 at 12:09 PM
	Inogen (INGN) Downgraded to Hold at BidaskClub www.americanbankingnews.com - March 3 at 11:10 PM
	Next Century Growth Investors LLC Has $5.42 Million Holdings in Inogen Inc (INGN) www.americanbankingnews.com - March 3 at 3:55 PM
	Inogen Inc (INGN) Position Raised by Arizona State Retirement System www.americanbankingnews.com - March 3 at 4:22 AM
	Heath Lukatch Sells 2,500 Shares of Inogen Inc (INGN) Stock www.americanbankingnews.com - March 2 at 6:56 PM
	FY2021 EPS Estimates for Inogen Inc Increased by Analyst (INGN) www.americanbankingnews.com - March 2 at 5:31 PM
	William Blair Analysts Raise Earnings Estimates for Inogen Inc (INGN) www.americanbankingnews.com - March 2 at 9:04 AM
	Q2 2018 EPS Estimates for Inogen Inc (INGN) Boosted by William Blair www.americanbankingnews.com - March 1 at 9:20 AM

Inogen (NASDAQ:INGN) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Inogen (NASDAQ:INGN) Income Statement, Balance Sheet and Cash Flow Statement

Inogen (NASDAQ INGN) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff